Skip to main content

STEPAN CO

For the period ended Jun 30, 2026. Filed Aug 5, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 5, 2026

SCL$68.09+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share amounts)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Net Sales$684,109$594,689$1,288,618$1,187,944
Cost of Sales584,127522,8041,123,7851,040,596
Gross Profit99,98271,885164,833147,348
Operating Expenses:
Selling14,86614,65727,03226,765
Administrative24,20322,80145,51644,215
Research, development and technical services17,19514,70132,18829,350
Deferred compensation expense1,4021,7611,964765
57,66653,920106,700101,095
Business restructuring (Note 16)5,106—70,545—
Operating Income (Loss)37,21017,965(12,412)46,253
Other Income (Expense):
Interest, net(5,682)(5,485)(10,693)(9,611)
Other, net (Note 15)1,0211,3061,1651,808
(4,661)(4,179)(9,528)(7,803)
Income (Loss) Before Provision for Income Taxes32,54913,786(21,940)38,450
Provision for Income Taxes9,6382,445(3,445)7,398
Net Income (Loss)22,91111,341(18,495)31,052
Net Income (Loss) Per Common Share (Note 10):
Basic$1.00$0.50$(0.81)$1.36
Diluted$1.00$0.50$(0.81)$1.36
Shares Used to Compute Net Income Per Common Share (Note 10):
Basic22,89722,86522,89322,866
Diluted22,92422,87922,89322,885

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Net Income (Loss)$22,911$11,341$(18,495)$31,052
Other Comprehensive Income (Loss):
Foreign currency translation adjustments (Note 11)2,18537,0842,44758,693
Defined benefit pension adjustments, net of tax (Note 11)14559290114
Derivative instrument activity, net of tax (Note 11)(334)(774)(439)(1,888)
Total Other Comprehensive Income1,99636,3692,29856,919
Comprehensive Income (Loss)$24,907$47,710$(16,197)$87,971

CONDENSED CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)June 30, 2026December 31, 2025
Assets
Current Assets:
Cash and cash equivalents$113,705$132,688
Receivables, net492,342387,959
Inventories (Note 6)324,463298,827
Other current assets44,25439,485
Total current assets974,764858,959
Property, Plant and Equipment:
Cost2,764,4352,787,036
Less: Accumulated depreciation(1,621,823)(1,567,409)
Property, plant and equipment, net1,142,6121,219,627
Goodwill, net91,74192,570
Other intangible assets, net36,13039,526
Long-term investments (Note 3)14,50721,270
Operating lease assets (Note 7)58,07162,494
Other non-current assets74,84163,256
Total assets$2,392,666$2,357,702
Liabilities and Equity
Current Liabilities:
Current maturities of debt (Note 14)$403,285$285,735
Accounts payable321,664261,723
Accrued liabilities122,049119,036
Total current liabilities846,998666,494
Deferred income taxes10,99811,450
Long-term debt, less current maturities (Note 14)244,069340,975
Non-current operating lease liabilities (Note 7)45,02849,340
Other non-current liabilities33,52745,433
Commitments and Contingencies (Note 8)
Equity:
Common stock, $1 par value; authorized 60,000,000 shares; 27,467,526 issued shares in 2026 and 27,301,177 issued shares in 202527,46827,301
Additional paid-in capital265,273259,820
Accumulated other comprehensive loss (Note 11)(136,676)(138,974)
Retained earnings1,249,3151,285,752
Less: Common treasury stock, at cost, 4,735,033 shares in 2026 and 4,676,739 shares in 2025(193,334)(189,889)
Total equity1,212,0461,244,010
Total liabilities and equity$2,392,666$2,357,702

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)Six Months Ended June 30,
20262025
Cash Flows From Operating Activities
Net income (loss)$(18,495)$31,052
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization63,86760,559
Deferred compensation (income) expense1,964765
Realized and unrealized loss on long-term investments(1,085)(1,074)
Stock-based compensation3,6203,064
Deferred income taxes(10,855)496
Business restructuring63,537—
Other non-cash items662412
Changes in assets and liabilities:
Receivables, net(104,289)(31,753)
Inventories(24,229)(30,652)
Other current assets(5,116)(10,765)
Accounts payable and accrued liabilities56,407(1,570)
Pension liabilities(116)(472)
Environmental and legal liabilities348(436)
Deferred revenues(922)(1,491)
Net Cash Provided By Operating Activities25,29818,135
Cash Flows From Investing Activities
Expenditures for property, plant and equipment(54,294)(58,346)
Other, net7,9786,878
Net Cash Used In Investing Activities(46,316)(51,468)
Cash Flows From Financing Activities
Revolving debt and bank overdrafts, net (Note 14)41,300(18,200)
Other debt borrowings—75,000
Other debt repayments(20,714)(24,286)
Dividends paid(17,942)(17,386)
Stock option exercises294104
Other, net(1,738)(1,974)
Net Cash Provided By Financing Activities1,20013,258
Effect of Exchange Rate Changes on Cash8359,314
Net Decrease in Cash and Cash Equivalents(18,983)(10,761)
Cash and Cash Equivalents at Beginning of Period132,68899,665
Cash and Cash Equivalents at End of Period$113,705$88,904
Supplemental Cash Flow Information
Cash payments of income taxes, net of refunds$9,629$4,590
Cash payments of interest$14,208$13,628

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2026

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The condensed consolidated financial statements included herein have been prepared by Stepan Company (the Company), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted pursuant to such rules and regulations, although management believes that the disclosures are adequate and make the information presented not misleading. In the opinion of management, all adjustments, consisting only of normal recurring accruals, necessary to present fairly the Company’s financial position as of June 30, 2026, its results of operations for the three and six months ended June 30, 2026 and 2025 and cash flows for the six months ended June 30, 2026 and 2025, have been included. These financial statements and related footnotes should be read in conjunction with the financial statements and related footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (2025 Annual Report on Form 10-K).

RECONCILIATIONS OF EQUITY

Below are reconciliations of total equity for thethree and six months ended June 30, 2026 and 2025:

(In thousands, except share and per share amounts)TotalCommonStockAdditionalPaid-inCapitalCommonTreasuryStockAccumulatedOtherComprehensiveIncome (Loss)RetainedEarnings
Balance, March 31, 2026$1,193,024$27,447$262,200$(193,334)$(138,672)$1,235,383
Issuance of 0 shares of common stock under incentive compensation plan——————
Stock-based and deferred compensation3,094213,073———
Net income22,911————22,911
Other comprehensive income1,996———1,996—
Cash dividends paid:
Common stock ($0.395 per share)(8,979)————(8,979)
Balance, June 30, 2026$1,212,046$27,468$265,273$(193,334)$(136,676)$1,249,315
(In thousands, except share and per share amounts)TotalCommonStockAdditionalPaid-inCapitalCommonTreasuryStockAccumulatedOtherComprehensiveIncome (Loss)RetainedEarnings
Balance, December 31, 2025$1,244,010$27,301$259,820$(189,889)$(138,974)$1,285,752
Issuance of 6,694 shares of common stock under incentive compensation plan2947287———
Stock-based and deferred compensation1,8811605,166(3,445)——
Net income (loss)(18,495)————(18,495)
Other comprehensive income2,298———2,298—
Cash dividends paid:
Common stock ($0.790 per share)(17,942)————(17,942)
Balance, June 30, 2026$1,212,046$27,468$265,273$(193,334)$(136,676)$1,249,315
(In thousands, except share and per share amounts)TotalCommonStockAdditionalPaid-inCapitalCommonTreasuryStockAccumulatedOtherComprehensiveIncome (Loss)RetainedEarnings
Balance, March 31, 2025$1,200,538$27,253$254,366$(189,706)$(176,288)$1,284,913
Issuance of 530 shares of common stock under incentive compensation plan22—22———
Stock-based and deferred compensation2,145382,187(80)——
Net income11,341————11,341
Other comprehensive income36,369———36,369—
Cash dividends paid:
Common stock ($0.385 per share)(8,702)————(8,702)
Balance, June 30, 2025$1,241,713$27,291$256,575$(189,786)$(139,919)$1,287,552
(In thousands, except share and per share amounts)TotalCommonStockAdditionalPaid-inCapitalCommonTreasuryStockAccumulatedOtherComprehensiveIncome (Loss)RetainedEarnings
Balance, December 31, 2024$1,169,934$27,156$253,779$(188,049)$(196,838)$1,273,886
Issuance of 2,473 shares of common stock under incentive compensation plan1042102———
Stock-based and deferred compensation1,0901332,694(1,737)——
Net income31,052————31,052
Other comprehensive income56,919———56,919—
Cash dividends paid:
Common stock ($0.770 per share)(17,386)————(17,386)
Balance, June 30, 2025$1,241,713$27,291$256,575$(189,786)$(139,919)$1,287,552

FAIR VALUE MEASUREMENTS

Cash and cash equivalents

Carrying value approximated fair value because of the short maturity of the instruments. Fair value of cash and cash equivalents is a Level 1 measurement. The Company's cash and cash equivalents included money market funds totaling $10,516,000 and $13,807,000 at June 30, 2026 and December 31, 2025, respectively.

Derivative assets and liabilities

Derivative assets and liabilities include the foreign currency exchange and interest rate swap contracts discussed in Note 4, Derivative Instruments, of the notes to the Company’s condensed consolidated financial statements (included in Item 1 of this Form 10-Q). Fair value and carrying value were the same because the contracts were recorded at fair value. The fair values of the foreign currency contracts were calculated as the difference between the applicable forward foreign exchange rates at the reporting date and the contracted foreign exchange rates multiplied by the contracted notional amounts. The fair value of the interest rate swap was calculated as the difference between the contracted swap rate and the floating interest rate multiplied by the present value of the notional amount of the contract.

The Company's fair value measurements for debt fall in Level 2 of the fair value hierarchy. At June 30, 2026, and December 31, 2025, the fair values and related carrying values of debt, including current maturities, were as follows (the fair valueand carrying value amounts are presented without regard to unamortized debt issuance costs of $217,000 and $275,000 as of June 30, 2026 and December 31, 2025, respectively):

(In thousands)June 30,2026December 31,2025
Fair value$636,220$619,027
Carrying value647,571626,985

The following tables present financial assets and liabilities, excluding cash and cash equivalents, measured on a recurring basis at fair value as of June 30, 2026, and December 31, 2025, and the level within the fair value hierarchy in which the fair value measurements fall:

(In thousands)June 30,2026Level 1Level 2Level 3
Mutual fund assets$14,507$14,507$—$—
Derivative assets:
Interest rate contracts1,540—1,540—
Foreign currency contracts451—451—
Total assets at fair value$16,498$14,507$1,991$—
Derivative liabilities:
Foreign currency contracts$575$—$575$—
(In thousands)December 31,2025Level 1Level 2Level 3
Mutual fund assets$21,270$21,270$—$—
Derivative assets:
Interest rate contracts1,974—1,974—
Foreign currency contracts423—423—
Total assets at fair value$23,667$21,270$2,397$—
Derivative liabilities:
Foreign currency contracts$340$—$340$—

DERIVATIVE INSTRUMENTS

At June 30, 2026, and December 31, 2025, the Company had open forward foreign currency exchange contracts to buy or sell foreign currencies with U.S. dollar equivalent amounts of $46,234,000 and $57,755,000, respectively. All forward foreign exchange contracts at June 30, 2026 had durations ofone month tothree months.

The Company is currently exposed to volatility in short-term interest rates and has mitigated certain portions of that risk by using an interest rate swap. The interest rate swap is recognized on the balance sheet as either an asset or a liability measured at fair value. At June 30, 2026, the Company held an interest rate swap contract with a notional value of $100,000,000 that was designated as a cash flow hedge. Period-to-period changes in the fair value of the interest rate swap are initially recognized as gains or losses in other comprehensive income. As the interest rate swap contract is settled, the corresponding gain or loss is reclassified out of accumulated other comprehensive income (AOCI) into earnings. The maturity date of the current interest rate swap contract is March 10, 2027, which is closely aligned with the June 24, 2027 maturity of the Company's revolving credit facility.

The fair values of the derivative instruments held by the Company on June 30, 2026, and December 31, 2025, are disclosed in Note 3, Fair Value Measurements, of the notes to the Company’s condensed consolidated financial statements (included in Item 1 of this Form 10-Q). Derivative instrument gains and losses for the three and six months ended June 30, 2026 and 2025, were immaterial. For amounts reclassified out of AOCI into earnings for the three and six months ended June 30, 2026 and 2025, see Note 11, Accumulated Other Comprehensive Income (Loss), of the notes to the Company’s condensed consolidated financial statements (included in Item 1 of this Form 10-Q).

STOCK-BASED COMPENSATION

Compensation expense recorded for all stock options, performance shares, time-based restricted stock units (RSUs) and stock appreciation rights (SARs) was as follows:

(In thousands)
Three Months EndedJune 30, · Six Months EndedJune 30,
2026202520262025
$2,117$1,682$3,620$3,064

Unrecognized compensation costs for stock options, performance shares, RSUs and SARs were as follows:

(In thousands)June 30,2026December 31,2025
Stock options$134$109
Performance shares and RSUs12,8306,838
SARs3,7342,602

The change in unrecognized compensation costs for stock options, performance shares, RSUs and SARs is due to new grants issued in 2026.

The Company granted the following awards in the first six months of 2026:

Shares
Stock options3,936
Performance shares (at target) and RSUs210,393
SARs146,539

The unrecognized compensation costs at June 30, 2026, are expected to be recognized over weighted-average periods of 2.0 years for stock options,2.2 years for performance shares and RSUs and 2.1 years for SARs.

INVENTORIES

The composition of inventories at June 30, 2026, and December 31, 2025, was as follows:

(In thousands)June 30,2026December 31,2025
Finished goods$221,319$220,094
Raw materials103,14478,733
Total inventories$324,463$298,827

LEASES

Lease cost is recognized in both the Cost of Sales and Operating Expenses sections of the Condensed Consolidated Statements of Income.

(In thousands)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Lease Cost
Operating lease cost$4,771$4,801$9,393$9,563
Short-term lease cost2,2702,7964,9725,314
Variable lease cost274393615768
Total lease cost$7,315$7,990$14,980$15,645
Other Information
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases$4,729$4,801$9,305$9,577
Right-of-use assets obtained in exchange for new operating lease liabilities886381,202260

The following table outlines the maturities of lease liabilities as of June 30, 2026.

(In thousands)
Undiscounted Cash Flows:
2026 (excluding the six months ended June 30, 2026)$9,197
202714,181
20289,820
20298,617
20307,193
Subsequent to 203017,619
Total Undiscounted Cash Flows$66,627
Less: Imputed interest(6,632)
Present value$59,995
Current operating lease liabilities (1)14,967
Non-current operating lease liabilities45,028
Total lease liabilities$59,995

(1)

This item is included in the Accrued liabilities line on the Company’s Condensed Consolidated Balance Sheet.

Weighted-average remaining lease term-operating leases6 Years
Weighted-average discount rate-operating leases3.9%

As of June 30, 2026, the Company hadno leases that had not commenced.

CONTINGENCIES

There are a variety of legal proceedings pending or threatened against the Company that occur in the normal course of the Company’s business, the majority of which relate to environmental assessment, protection and remediation matters. Some of these proceedings may result in fines, penalties, judgments or costs being assessed against the Company at some future time. The Company’s operations are subject to extensive local, state and federal regulations, including the U.S. Comprehensive Environmental Response, Compensation and Liability Act of 1980 (CERCLA) and the Superfund amendments of 1986 (Superfund) as well as comparable regulations applicable to the Company’s foreign locations. Over the years, the Company has received requests for information related to or has been named by government authorities as a potentially responsible party at a number of sites where cleanup costs have been or may be incurred by the Company under CERCLA and similar state statutes. In addition, the Company is from time to time involved in routine legal proceedings incidental to the conduct of its business, including personal injury, property damage, tax, trade and labor matters. The Company believes that it has made adequate provisions for the costs it is likely to incur with respect to these claims.

In determining the appropriate level of environmental reserves, the Company considers several factors such as information obtained from investigatory studies; changes in the scope of remediation; the interpretation, application and enforcement of laws and regulations; changes in the costs of remediation programs; the development of alternative cleanup technologies and methods; and the relative level of the Company’s involvement at various sites for which the Company is allegedly associated. The level of annual expenditures for remedial, monitoring and investigatory activities will change in the future as major components of planned remediation activities are completed and the scope, timing and costs of existing activities are changed. As of June 30, 2026, the Company estimated a range of possible environmental losses and legal losses of $19,619,000 to $46,483,000. Within the range of possible environmental losses and legal losses, management has currently concluded that no single amount is more likely to occur than any other amounts in the range and, thus, has accrued at the lower end of the range. These accruals totaled $19,619,000 at June 30, 2026 and $19,272,000 at December 31, 2025. Although the Company believes that its estimated range of possible environmental losses and legal losses and its reserves are adequate for contingencies, it is possible, due to uncertainties including those noted above, that additional reserves could be required in the future. Cash expenditures related to environmental remediation and certain other legal matters approximated $749,000 and $3,402,000 for thesix months ended June 30, 2026 and 2025, respectively.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Based on the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, management believes that the Company has no material liability at these sites and that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material.

Following are summaries of the Company’s major contingencies at June 30, 2026:

Maywood, New Jersey Site

The Company’s property in Maywood, New Jersey, property formerly owned by the Company adjacent to its current site and other nearby properties (collectively, the Maywood site) were listed on the National Priorities List in September 1993 pursuant to the provisions of CERCLA because of alleged chemical and radiological contamination. Pursuant to (i) a September 21, 1987 Administrative Order on Consent entered into between the U.S. Environmental Protection Agency (USEPA) and the Company for property formerly owned by the Company at the Maywood site and (ii) the issuance of an order on May 2, 1991 by the USEPA to the Company for property currently owned by the Company at the Maywood site, the Company has completed various Remedial Investigation/Feasibility Studies of soil and groundwater at the Maywood site. On September 24, 2014, the USEPA issued its Record of Decision (ROD) for chemically-contaminated soil at the Maywood site. The ROD was amended pursuant to an Explanation of Significant Differences in January 2021. On February 29, 2024, the U.S. District Court for the District of New Jersey entered a consent decree among the Company, the United States, the New Jersey Department of Environmental Protection (NJDEP) and the New Jersey Spill Compensation Fund Administrator that requires the Company to take certain actions and to pay certain past costs of the United States and NJDEP. The USEPA has not yet issued a ROD for chemically-contaminated groundwater at the Maywood site.

Based on the most current information available, the Company believes its recorded liability is reasonable having considered the range of estimated costs of remediation for the Maywood site. The estimate of the cost of remediation for the Maywood site could change again as the Company continues to hold discussions with the USEPA, as the design of the remedial action is finalized, if a groundwater ROD is issued or if other potentially responsible parties are identified. The ultimate amount for which the Company is liable could differ materially from the Company’s current recorded liability.

D’Imperio Property Site

During the mid-1970’s, Jerome Lightman and the Lightman Drum Company disposed of hazardous substances generated by the Company at several sites in New Jersey, including the D’Imperio site. The Company was named as a potentially responsible party in an October 2, 1998 lawsuit in the U.S. District Court for the District of New Jersey that involved the D’Imperio Site. The Company is cooperating with other potentially responsible parties to implement the selected remedy. Based on current information, the Company believes that its recorded liability is reasonable having considered the range of estimated cost of remediation for the D’Imperio site. Depending on the ultimate cost of the remediation at this site, the amount for which the Company is liable could differ materially from the Company’s current recorded liability.

Wilmington Site

Property formerly owned and operated by the Company in Wilmington, Massachusetts was listed on the National Priorities List in 2006. The Company, together with the current site owner and another potentially responsible party, entered into an Administrative Order on Consent in July 2007 to undertake a Remedial Investigation and Feasibility Study. A ROD was issued by the USEPA on March 30, 2021. The Company and three other potentially responsible parties entered into a consent decree, dated September 28, 2023, with USEPA and the Commonwealth of Massachusetts that requires the remedial design and remedial action of the remedy selected in the ROD for two operable units and an interim remedy for another operable unit. Remediation at this site is being managed by its current owner, to whom the Company sold the property in 1980. The Company is contractually obligated to contribute up tofive percent of the environmental response costs incurred by the current owner, with no limitation on the ultimate amount of contributions. The Company had paid the current owner $4,443,000 for the Company’s portion of environmental response costs at the Wilmington site through June 30, 2026. The Company has recorded a liability for its portion of the estimated remediation costs for the site. Depending on the ultimate cost of the remediation at this site, the amount for which the Company is liable could differ materially from the current recorded liability.

On July 29, 2022, the Company and other potentially responsible parties were notified of a possible joint claim by federal and state trustees for alleged natural resource damages related to the Wilmington site. The alleged damages may result in a range of possible penalties and the Company recorded a liability for this matter during the first quarter of 2024. Depending on the ultimate resolution of this matter, the amount for which the Company is liable could differ materially from the current recorded liability.

Millsdale Site

On March 26, 2024, the Company received a Notice and Finding of Violation from the USEPA alleging violations of air regulations at the Company’s Elwood, Illinois (Millsdale) facility. The notice alleges violations related to operating parameters and air emission requirements. The alleged violations may result in a range of possible penalties, including financial penalties or operational remedies. Based on current information, the Company believes that its recorded liability for this matter is reasonable; however, depending on the ultimate resolution of this matter, the amount for which the Company is liable could differ materially from the current recorded liability.

Other U.S. Sites

Through the regular environmental monitoring of its plant production sites, the Company discovered levels of chemical contamination that were above thresholds allowed by law at its Millsdale and Fieldsboro, New Jersey plants. The Company voluntarily reported its results to the applicable state environmental agencies. As a result, the Company is required to perform self-remediation of the affected areas. Based on current information, the Company believes that its recorded liability for the remediation of the affected areas is appropriate based on an estimate of expected costs. However, actual costs could differ materially from the current recorded liability.

Brazil Tax Rescission Action

In March 2017, the Brazil Supreme Court ruled that ICMS (State VAT) does not represent a Company’s revenue and should not be included in the calculation basis of certain indirect taxes (PIS/COFINS). Based on the Supreme Court’s decision, the Company’s Brazilian subsidiary filed a lawsuit on March 23, 2017 to recover PIS/COFINS overpayments. The Company’s recovery case was successful and became final in November 2018. In May 2021, the Brazil Supreme Court modulated its original decision so that only taxpayers that had filed lawsuits before March 15, 2017, should recover prior PIS/COFINS overpayments. On June 12, 2023, the Brazil National Treasury filed a rescission action against the Company’s Brazilian subsidiary to rescind its use of the PIS/COFINS tax credits for the period from March 23, 2012, to March 15, 2017. In September and October 2024, the Brazil Superior Court and Supreme Court, respectively, ruled that the generally held two-year “res judicata” principle would start from the May 2021 ruling and not the final ruling in prior taxpayer cases (e.g., November 30, 2018, for the Company’s case). Based on current information, the Company believes that its recorded liability is reasonable; however, depending on the ultimate resolution of this matter, the amount for which the Company is liable could differ materially from the current recorded liability.

Other Matters

On March 19, 2025, the Company received a pre-filing notice from USEPA for alleged violations of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) associated with certain of the Company’s biocide products sold by a licensed distributor. USEPA assessed a civil penalty of $1,126,000, which the Company paid on July 2, 2025. As of June 30, 2026, the Company recovered the entire amount of the USEPA penalty from third parties.

POSTRETIREMENT BENEFIT PLANS

Defined Benefit Pension Plans

The Company sponsors various funded qualified and unfunded non-qualified defined benefit pension plans, the most significant of which cover employees in the U.S. and U.K. locations. The U.S. and U.K. defined benefit pension plans are frozen and service benefits are no longer being accrued.

Components of Net Periodic Benefit Cost

UNITED STATES
(In thousands)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Interest cost$1,646$1,700$3,292$3,400
Expected return on plan assets(1,847)(2,003)(3,695)(4,005)
Amortization of net actuarial loss (gain)109(19)217(38)
Net periodic benefit cost$(92)$(322)$(186)$(643)
UNITED KINGDOM
(In thousands)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Interest cost$178$178$357$346
Expected return on plan assets(201)(206)(403)(400)
Amortization of net actuarial loss8597170189
Net periodic benefit cost$62$69$124$135

Employer Contributions

U.S. Plans

In 2026, the Company expects to contribute $880,000 to the U.S. qualified defined benefit plans and $147,000 to the U.S. unfunded non-qualified pension plans. Of such amount, $89,000 had been paid to the non-qualified plans as of June 30, 2026.

U.K. Plan

The Company’s U.K. subsidiary does not expect to contribute to its defined benefit pension plan in 2026.

Defined Contribution Plans

The Company sponsors retirement defined contribution plans that cover eligible U.S. and U.K. employees. The Company’s U.S. retirement plans include two qualified plans, one of which is a 401(k) plan and one of which is an employee stock ownership plan (profit sharing plan), and one non-qualified supplemental executive plan. In the six months ended June 30, 2026 and 2025, the Company made contributions into the qualified retirement plans for U.S. employees and for certain non-U.S. employees. Profit sharing contributions were determined using a formula applied to Company earnings. Approximately 85 percent of union and non-union employees are eligible for either the Company's sponsored or statutory profit sharing contributions and 100 percent of U.S. based union and non-union employees are eligible for the Company's sponsored profit sharing contributions. In 2025 and 2026, profit sharing contributions for U.S. employees were made to the employee stock ownership plan. Profit sharing contributions are allocated to participant accounts based on participant base earnings.

Defined contribution plan expenses for the Company’s qualified contribution plans were as follows:

(In thousands)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Retirement savings contributions$2,410$2,344$4,654$4,559
Profit sharing contributions1,1074951,6681,605
Total defined contribution plan expenses$3,517$2,839$6,322$6,164

The Company has a rabbi trust to fund the obligations of its non-qualified supplemental executive defined contribution plans (supplemental plans). The trust is comprised of various mutual fund investments selected by the participants of the supplemental plans. In accordance with the accounting guidance for rabbi trust arrangements, the assets of the trust and the obligations of the supplemental plans are reported on the Company’s condensed consolidated balance sheets. The Company elected the fair value option for the mutual fund investment assets so that offsetting changes in the mutual fund values and defined contribution plan obligations would be recorded in earnings in the same period. Therefore, the mutual funds are reported at fair value with any subsequent changes in fair value recorded in the statements of income. The supplemental plan liabilities increase (i.e., supplemental plan expense is recognized) when the value of the trust assets appreciate and decrease when the value of the trust assets decline (i.e., supplemental plan income is recognized). At June 30, 2026, the balance of the trust assets was $354,000 which equaled the balance of the supplemental plan liabilities. See the long-term investments section in Note 3, Fair Value Measurements, of the notes to the Company’s condensed consolidated financial statements (included in Item 1 of this Form 10-Q) for further information regarding the Company’s mutual fund assets.

EARNINGS PER SHARE

Below are the computations of basic and diluted earnings per share for thethree and six months ended June 30, 2026 and 2025:

(In thousands, except per share amounts)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Computation of Basic Earnings per Share
Net income (loss)$22,911$11,341$(18,495)$31,052
Weighted-average number of common shares outstanding22,89722,86522,89322,866
Basic earnings per share$1.00$0.50$(0.81)$1.36
Computation of Diluted Earnings per Share
Net income (loss)$22,911$11,341$(18,495)$31,052
Weighted-average number of shares outstanding22,89722,86522,89322,866
Add weighted-average net shares from assumed exercise of options (under treasury stock method)(1)(2)—7—10
Add weighted-average net shares related to unvested stock awards (under treasury stock method)(2)192—2
Add weighted-average net shares from assumed exercise of SARs (under treasury stock method)(1)(2)—5—7
Add weighted-average contingently issuable net shares related to performance stock awards (under treasury stock method)(2)8———
Weighted-average shares applicable to diluted earnings22,92422,87922,89322,885
Diluted earnings per share$1.00$0.50$(0.81)$1.36

(1)

Options/SARs to acquire 1,167,695 shares of the Company's common stock were excluded from the computation of dilutive earnings per share for the three months ended June 30, 2026. Options/SARs to acquire 1,205,183 and 1,209,553 shares of the Company's common stock were excluded from the computation of dilutive earnings per share for thethree and six months ended June 30, 2025, respectively. The options/SARs' exercise prices were greater than the average market price for the Company's common stock and inclusion of the instruments would have had an antidilutive effect on the computations of the earnings per share.

(2)

For the six months ended June 30, 2026, potential common shares were excluded from the computation of diluted earnings per share because of their anti-dilutive effect due to the net loss for the first six months in 2026.

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

Below is the change in the Company’s accumulated other comprehensive income (loss) (AOCI) balance by component (net of income taxes) for thethree and six months ended June 30, 2026 and 2025:

(In thousands)ForeignCurrencyTranslationAdjustmentsDefinedBenefitPension PlanAdjustmentsCash FlowHedgeAdjustmentsTotal
Balance at March 31, 2025$(154,193)$(25,941)$3,846$(176,288)
Other comprehensive income (loss) before reclassifications37,084—(771)36,313
Amounts reclassified from AOCI—59(3)56
Net current-period other comprehensive income (loss)37,08459(774)36,369
Balance at June 30, 2025$(117,109)$(25,882)$3,072$(139,919)
Balance at March 31, 2026$(113,720)$(26,837)$1,885$(138,672)
Other comprehensive income (loss) before reclassifications2,185—(331)1,854
Amounts reclassified from AOCI—145(3)142
Net current-period other comprehensive income (loss)2,185145(334)1,996
Balance at June 30, 2026$(111,535)$(26,692)$1,551$(136,676)
Balance at December 31, 2024$(175,802)$(25,996)$4,960$(196,838)
Other comprehensive income (loss) before reclassifications58,693—(1,883)56,810
Amounts reclassified from AOCI—114(5)109
Net current-period other comprehensive income (loss)58,693114(1,888)56,919
Balance at June 30, 2025$(117,109)$(25,882)$3,072$(139,919)
Balance at December 31, 2025$(113,982)$(26,982)$1,990$(138,974)
Other comprehensive income (loss) before reclassifications2,447—(434)2,013
Amounts reclassified from AOCI—290(5)285
Net current-period other comprehensive income (loss)2,447290(439)2,298
Balance at June 30, 2026$(111,535)$(26,692)$1,551$(136,676)

Information regarding the reclassifications out of AOCI for thethree and six months ended June 30, 2026 and 2025, is displayed below:

(In thousands)Amount Reclassified from AOCI (1)
AOCI Components · Three Months EndedJune 30, · Six Months EndedJune 30, · Affected Line Item in Condensed ConsolidatedStatements of Income
2026 · 2025 · 2026 · 2025
Amortization of defined benefit pension actuarial losses$(194)$(78)$(387)$(151)(2)
49199737Tax benefit
$(145)$(59)$(290)$(114)Net of tax
Gains and losses on cash flow hedges:
Foreign exchange contracts3355Cost of sales
3355Total before tax
————Tax benefit
$3$3$5$5Net of tax
Total reclassifications for the period$(142)$(56)$(285)$(109)Net of tax

(1)

Amounts in parentheses denote expense to the Company’s Condensed Consolidated Statements of Income.

(2)

This component of accumulated other comprehensive income is included in the computation of net periodic benefit cost. See Note 9, Postretirement Benefit Plans, of the notes to the Company’s condensed consolidated financial statements (included in Item 1 of this Form 10-Q) for additional details.

SEGMENT REPORTING

The Company hasthree reportable segments: Surfactants, Polymers and Specialty Products. The Company’s Chief Operating Decision Maker (CODM) is the President and Chief Executive Officer. The accounting policies of the reportable segments are the same as those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025. The following is segment data for thethree and six months ended June 30, 2026 and 2025, and reconciliations of segment data to the condensed consolidated financial statements:

(In thousands) · Surfactants · Polymers · SpecialtyProducts · Total
Net Sales$483,902$178,007$22,200$684,109
Cost of Sales (1)420,295147,22816,193583,716
Operating Expenses (2)29,2458,3101,00038,555
Operating Income$34,362$22,469$5,007$61,838
Unallocated Corporate Expenses (3)———(24,628)
Consolidated Operating Income$37,210
Segment Capital Expenditures$16,057$6,517$992$23,566
Unallocated Capital Expenditures (4)———(160)
Consolidated Capital Expenditures$23,406
Segment Depreciation and Amortization$20,520$8,698$1,467$30,685
Unallocated Depreciation and Amortization (5)———235
Consolidated Depreciation and Amortization$30,920
(In thousands) · Surfactants · Polymers · SpecialtyProducts · Total
Net Sales$937,589$308,036$42,993$1,288,618
Cost of Sales (1)830,312261,27331,3661,122,951
Operating Expenses (2)54,36715,4721,90571,744
Operating Income$52,910$31,291$9,722$93,923
Unallocated Corporate Expenses (3)——(106,335)
Consolidated Operating Income$(12,412)
Segment Capital Expenditures$38,440$13,795$2,454$54,689
Unallocated Capital Expenditures (4)———(395)
Consolidated Capital Expenditures$54,294
Segment Depreciation and Amortization$43,088$17,274$2,920$63,282
Unallocated Depreciation and Amortization (5)———585
Consolidated Depreciation and Amortization$63,867
(In thousands) · Surfactants · Polymers · SpecialtyProducts · Total
Net Sales$411,456$162,751$20,482$594,689
Cost of Sales (1)370,660138,12414,293523,077
Operating Expenses (2)27,4297,46893135,828
Operating Income$13,367$17,159$5,258$35,784
Unallocated Corporate Expenses (3)———(17,819)
Consolidated Operating Income$17,965
Segment Capital Expenditures$19,675$4,581$866$25,122
Unallocated Capital Expenditures (4)———476
Consolidated Capital Expenditures$25,598
Segment Depreciation and Amortization$21,137$8,352$1,472$30,961
Unallocated Depreciation and Amortization (5)———328
Consolidated Depreciation and Amortization$31,289
(In thousands) · Surfactants · Polymers · SpecialtyProducts · Total
Net Sales$841,793$308,867$37,284$1,187,944
Cost of Sales (1)747,326269,02024,6901,041,036
Operating Expenses (2)52,17014,6701,82868,668
Operating Income$42,297$25,177$10,766$78,240
Unallocated Corporate Expenses (3)———(31,987)
Consolidated Operating Income$46,253
Segment Capital Expenditures$43,679$11,652$1,946$57,277
Unallocated Capital Expenditures (4)———1,069
Consolidated Capital Expenditures$58,346
Segment Depreciation and Amortization$40,567$16,413$2,961$59,941
Unallocated Depreciation and Amortization (5)———618
Consolidated Depreciation and Amortization$60,559

The following is segment assets at June 30, 2026 and December 31, 2025, and reconciliations of segment assets to the condensed consolidated financial statements.

(In thousands) · Surfactants · Polymers · SpecialtyProducts · Total
Segment Assets$1,650,031$545,676$85,116$2,280,823
Unallocated Assets (6)———111,843
Consolidated Assets$2,392,666
(In thousands)SurfactantsPolymersSpecialtyProductsTotal
Segment Assets$1,630,551$536,748$82,300$2,249,599
Unallocated Assets (6)———108,103
Consolidated Assets$2,357,702

(1)

Cost of sales is comprised of raw material costs (including freight and shipping/handling expenses to deliver the raw materials), manufacturing plant labor expenses and other manufacturing overhead expenses, such as utilities, maintenance, depreciation, etc. that can be allocated to reportable segments.

(2)

Operating expenses allocated to reportable segments are comprised of selling, administrative and research and development expenses. The CODM uses operating expenses in aggregate to analyze the performance of each reportable segment.

(3)

Unallocated corporate expenses are primarily comprised of corporate administrative expenses (e.g., corporate finance, legal, human resources, information technology and environmental remediation expenses), deferred compensation and business restructuring expenses that are not included in segment operating income and not used to evaluate segment performance.

(4)

Unallocated capital expenditures primarily include capital expenditures related to the Company’s Northfield, Illinois location.

(5)

Unallocated depreciation and amortization primarily includes depreciation related to the Company’s Northfield, Illinois location.

(6)

Unallocated assets primarily include assets in the Company’s Northfield, Illinois location.

REVENUE FROM CONTRACTS WITH CUSTOMERS

The Company has accounts receivable financing programs under which the Company has the ability to sell eligible receivables for select customers to select banking institutions. For the three months ended June 30, 2026 and 2025, the Company’s cash proceeds from the sale of receivables were $24,496,000 and $20,606,000, respectively. For thesix months ended June 30, 2026 and 2025, the Company’s cash proceeds from the sale of receivables were $40,114,000 and $55,075,000, respectively. Financing charges incurred from the sale of accounts receivable qualifying as sales for thethree and six months ended June 30, 2026 and 2025 were immaterial.

As of June 30, 2026 and December 31, 2025, the Company had $405,000 and $218,000 of contract liabilities andno contract assets, respectively. A contract liability would typically arise when an advance or deposit is received from a customer before the Company recognizes revenue. In practice, this is rare as it would require a customer to make a payment prior to a performance obligation being satisfied. When such situations do arise, the Company maintains a deferred revenue liability until the time a performance obligation has been satisfied. The Company recognized $218,000 of revenue in the first six months of 2026 from pre-existing contract liabilities at December 31, 2025.

In addition, during 2020, the Company recorded $10,709,000 of long-term deferred revenue associated with a payment received to defray the cost of capital expenditures necessary to service a customer’s future product needs. At June 30, 2026, $1,108,000 was classified as long-term and $2,216,000 was classified as short-term. This deferred revenue is being recognized over the period of the contract and $7,385,000 of revenue has been recognized from the beginning of the contract term through June 30, 2026.

The tables below provide a geographic disaggregation of net sales for thethree and six months ended June 30, 2026 and 2025. The Company’s business segmentation by geographic region most effectively captures the nature and economic characteristics of the Company’s revenue streams impacted by economic factors.

(In thousands)For the Three Months Ended June 30, 2026
Geographic MarketSurfactantsPolymersSpecialtyTotal
North America$273,715$99,245$19,799$392,759
Europe81,96567,3072,326151,598
Latin America123,5086975123,652
Asia4,71411,386—16,100
Total$483,902$178,007$22,200$684,109
(In thousands)For the Six Months Ended June 30, 2026
Geographic MarketSurfactantsPolymersSpecialtyTotal
North America$532,810$171,047$37,910$741,767
Europe176,126114,8414,961295,928
Latin America220,118275122220,515
Asia8,53521,873—30,408
Total$937,589$308,036$42,993$1,288,618
(In thousands)For the Three Months Ended June 30, 2025
Geographic MarketSurfactantsPolymersSpecialtyTotal
North America$234,364$88,251$16,833$339,448
Europe74,60563,2963,514141,415
Latin America90,52720413590,866
Asia11,96011,000—22,960
Total$411,456$162,751$20,482$594,689
(In thousands)For the Six Months Ended June 30, 2025
Geographic MarketSurfactantsPolymersSpecialtyTotal
North America$486,099$161,044$30,297$677,440
Europe156,203124,4386,781287,422
Latin America173,291500206173,997
Asia26,20022,885—49,085
Total$841,793$308,867$37,284$1,187,944

DEBT

At June 30, 2026 and December 31, 2025, debt was comprised of the following:

(In thousands)Maturity DatesJune 30,2026December 31,2025
Senior unsecured notes
3.95% (net of unamortized debt issuance cost of $34 and $56 for 2026 and 2025, respectively)2026-2027$28,538$28,515
2.30% (net of unamortized debt issuance cost of $44 and $55 for 2026 and 2025, respectively)2026-202819,95629,945
2.37% (net of unamortized debt issuance cost of $49 and $60 for 2026 and 2025, respectively)2026-202829,95129,940
2.73% (net of unamortized debt issuance cost of $43 and $52 for 2026 and 2025, respectively)2026-203185,67085,662
2.83% (net of unamortized debt issuance cost of $47 and $52 for 2026 and 2025, respectively)2026-203264,23974,948
6.17% (net of unamortized debt issuance cost of $0 and $0 for 2026 and 2025, respectively)2029-203375,00075,000
Revolving credit facility and term loan borrowing2026-2027344,000302,700
Total debt$647,354$626,710
Less current maturities403,285285,735
Long-term debt$244,069$340,975

The Company's long-term debt financing is comprised of certain senior unsecured notes issued to insurance companies in private placement transactions pursuant to note purchase agreements (the “Note Purchase Agreements”), totaling $303,354,000 as of June 30, 2026. These notes are denominated in U.S. dollars and have fixed interest rates ranging from 2.30 percent to 6.17 percent. The notes had original maturities ofseven to 12 years with mandatory principal payments beginning four, five and six years after issuance. The Company will be required to make principal payments on the currently outstanding notes from 2026 to 2033.

The Company’s credit agreement (the Credit Agreement) with a syndicate of banks provides for credit facilities in an initial aggregate principal amount of $450,000,000, consisting of (a) a $350,000,000 multi-currency revolving credit facility and (b) a $100,000,000 delayed draw term loan credit facility, each of which matures on June 24, 2027. The Company's credit agreement with Credit Industriel et Commercial NY (the CIC Credit Agreement) provides for a credit facility in an aggregate principal amount of $8,700,000. The facility is for the sole purpose of the issuance of standby letters of credit. As of June 30, 2026, the Company had an outstanding letter of credit of $8,694,000 under the CIC Credit Agreement. The Company maintains import and export letters of credit, and standby letters of credit under its workers’ compensation insurance agreements and for other purposes, as needed from time to time, which are issued under the Credit Agreement and under the CIC Credit Agreement. As of June 30, 2026, the Company had outstanding letters of credit totaling $4,585,000 and $344,000,000 of outstanding borrowings under the Credit Agreement, inclusive of an $80,000,000 delayed-draw term loan ($20,000,000 of the term loan principal has been permanently repaid as scheduled). There was $81,415,000 available under the Credit Agreement as of June 30, 2026.

The Company's foreign subsidiaries hadno debt outstanding at June 30, 2026.

The Company’s material debt agreements contain provisions which, among other covenants, require maintenance of certain financial ratios and place limitations on additional debt, investments and payment of dividends. Based on the loan agreement provisions that place limitations on dividend payments, unrestricted retained earnings (i.e., retained earnings available for dividend distribution) were $227,780,000 and $263,923,000 at June 30, 2026 and December 31, 2025, respectively.

OTHER, NET

Other, net in the condensed consolidated statements of income included the following:

(In thousands)Three Months EndedJune 30,Six Months EndedJune 30,
2026202520262025
Foreign exchange (loss)$(379)$(639)$(197)$(20)
Investment income170125215246
Realized and unrealized gain on investments1,1991,5671,0851,074
Net periodic benefit cost3125362508
Other, net$1,021$1,306$1,165$1,808

BUSINESS RESTRUCTURING

In February 2026, as part of the Company's Project Catalyst, a comprehensive operational and efficiency plan, the Company’s Board of Directors approved plans to shut down the Company’s Fieldsboro, New Jersey site and decommission select assets at its Elwood, Illinois (Millsdale) and Stalybridge, U.K. facilities during the first half of 2026. The Company is mostly consolidating the impacted operations into its existing network, improving its asset utilization and reducing its fixed cost basis, while maintaining ongoing supply for its customers. Total pre-tax business restructuring expenses related to the asset shutdowns for the second quarter of 2026 and the first six months of 2026 were $5,106,000 and $70,545,000, respectively. Restructuring costs in the first half of 2026 included $61,309,000 of asset impairment charges. The Fieldsboro, New Jersey site, Elwood, Illinois (Millsdale) site and Stalybridge, U.K site recognized $42,109,000, $14,332,000 and $4,868,000, respectively, in asset impairment charges. During the first six months of 2026, the Company also recognized $7,509,000 and $1,727,000 of decommissioning/other and termination expenses, respectively.

Although all restructuring charges related to the Surfactants segment, they were excluded from the Surfactants segment results and are shown on a separate Business restructuring line item in the Condensed Consolidated Statements of Income for the three and six months ended June 30, 2026 and 2025. Below is a reconciliation of the beginning and ending balances of the restructuring liability:

(In thousands)Decommissioning and Other ChargesTerminationBenefitsTotal
Restructuring liability at January 1, 2026$—$—$—
Expenses accrued during the period1,4058152,220
Amounts paid———
Foreign currency translation———
Restructuring liability at March 31, 2026$1,405$815$2,220
Expenses accrued during the period3,299773,376
Amounts paid(2,888)(775)(3,663)
Foreign currency translation(3)74
Restructuring liability at June 30, 2026$1,813$124$1,937

The Company anticipates recognizing total restructuring expenses in the range of $75,000,000 to $80,000,000 for full year 2026.

NONCASH INVESTING AND FINANCING ACTIVITIES

Noncash investing activities included liabilities (accounts payable) incurred for property, plant and equipment expenditures of approximately $7,875,000 and $10,593,000 that were unpaid at June 30, 2026 and 2025, respectively. Noncash financing activities included the issuance of 159,655 shares of the Company’s common stock (valued at $8,602,000) and 132,057 shares of the Company’s common stock (valued at $7,811,000) under the Company’s equity incentive compensation plan during the period ended June 30, 2026 and 2025, respectively.

PURCHASE AND SALE AGREEMENT TO SELL LAND

On April 24, 2026, the Company entered into a Purchase and Sale Agreement to sell a parcel of the Company’s land near its Elwood, IL (Millsdale) site. The agreed upon purchase price for the property is $30,000,000 and is subject to customary adjustments and closing conditions. The transaction is expected to close during the second half of 2026.

RECENT ACCOUNTING PRONOUNCEMENTS

In November 2024, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2024-03, Income Statement - Reporting Comprehensive income - Expense Disaggregation Disclosures (Subtopic 220-40). This update requires that public entities on an interim and annual basis disclose, in the notes to financial statements, specified information about certain costs and expenses. ASU No. 2024-03 requires a footnote disclosure in tabular form of each expense caption on the face of the income statement that includes any of the following natural expenses: (1) purchases of inventory, (2) employee compensation, (3) depreciation, and (4) intangible asset amortization. The disclosure would also include a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclosure of the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. This ASU does not change or remove existing expense disclosure requirements; however, it may affect where that information appears in the footnotes to the financial statements. In January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive income - Expense Disaggregation Disclosures (Subtopic 220-40), Clarifying the effective date. The amendments in ASU No. 2024-03 are effective for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. The amendments in this update should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to any or all prior periods presented in the financial statements. The implementation of ASU No. 2024-03 will not have an impact on the Company’s financial position, results of operations and cash flow but will impact the Company’s interim and annual disclosures related to the relevant subtopics in this update.

In September 2025, the FASB issued ASU No. 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40) An Amendment of the FASB Accounting Standards Codification - Targeted Improvements to the Accounting for Internal-Use Software. This update removes all references to software development stages, allowing entities to start capitalizing software costs when 1) management has authorized and is committed to funding the software projects and 2) it is probable that the project will be completed and the software will be used to perform the functions intended. Under the current rule, entities are required to capitalize development costs incurred depending on the nature of the costs and the project stage during which they occur. The amendments in this update are effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. Early adoption is permitted as of the beginning of the annual reporting period. The Company is in the process of evaluating ASU 2025-06 to determine its impact, if any, on the Company’s financial position, results of operations and cash flows.

In May 2026, the FASB issued ASU No. 2026-02, Environmental Credits and Environmental Credit Obligations (Topic 818). This update provides recognition, measurement, presentation, and disclosure requirements for all entities that generate, purchase, receive environmental credits or have regulatory compliance obligations that may be settled with environmental credits. Environmental credits include carbon offsets, emission allowances, renewable energy certificates, and renewable identification numbers. Environmental obligations are regulatory obligations arising from laws to prevent, control, reduce, or remove emissions or pollution, which may be settled with environmental credits. Entities will need to disclose intended use of credits, financial statement impact of environmental assets and liabilities and changes in intent to use credits to settle existing obligations. The amendments in this update are effective for annual periods beginning after December 15, 2027, and interim periods within those annual reporting periods. The Company is in the process of evaluating ASU 2026-02 to determine its impact, if any, on the Company’s financial position, results of operations and cash flows.

SUBSEQUENT EVENT

On July 28, 2026, the Board of Directors (the “Board”) of the Company approved a plan to reduce the Company’s global salaried workforce by around 100 roles during the third quarter of 2026 as part of Project Catalyst, the Company’s previously announced comprehensive operational and efficiency initiative.

As previously disclosed, the Company anticipates recognizing full-year restructuring charges in the range of $75,000,000 to $80,000,000 in connection with Project Catalyst. Of that amount, the Company currently estimates that it will incur approximately $4,000,000 to $6,000,000 ofcharges in connection with the workforce reduction, consisting primarily of employee severance, benefits and related costs. The Company expects substantially all of these workforce reduction charges toresult in cash expenditures. The Company expects to recognize the majority of these charges during the second half of 2026.

The estimated charges that the Company expects to incur are subject to several assumptions, and actual results may differ materially from these estimates. The Company may incur additional costs due to events associated with or resulting from Project Catalyst and the workforce reduction described above.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.